Stay updated on IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe revision history now shows a new entry Revision: v3.6.4 and removes Revision: v3.6.3, updating the page's revision history metadata.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's revision label in the history section updated from v3.6.2 to v3.6.3, representing a minor update to the page's revision tracking.SummaryDifference0.1%

- Check43 days agoChange DetectedThe record’s revision label was updated from v3.6.0 to v3.6.2. This indicates a new revision of the study record.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision (v3.6.0) on 2026-05-25 added the Contacts/Locations and Study Status sections, and a subsequent 2026-06-12 entry notes that the study is no longer looking for participants. An older revision (v3.5.5) was removed on 2025-07-09.SummaryDifference1%

- Check65 days agoChange DetectedA new revision entry v3.5.5 was added to the revision history, and the earlier revision v3.5.4 was removed, updating the page's versioning metadata.SummaryDifference0.1%

- Check86 days agoChange DetectedThe header shows Revision: v3.5.4, replacing the prior Revision: v3.5.3, indicating a new build of the page interface.SummaryDifference0.1%

Stay in the know with updates to IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.